Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats

The moxidectin (MXD) is an antiparasitic drug used in domestic animals. The mechanism of action, in mammals, involves GABA, a neurotransmitter with an important role in the sexual behavior control. Presently, the effects of 0.2 mg/kg therapeutic dose were studied on sexual behavior, sexual motivatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research in veterinary science 2008-02, Vol.84 (1), p.100-106
Hauptverfasser: Rodrigues-Alves, Patricia S.B., Lebrun, Ivo, Flório, Jorge Camilo, Bernardi, Maria M., Spinosa, Helenice de S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 1
container_start_page 100
container_title Research in veterinary science
container_volume 84
creator Rodrigues-Alves, Patricia S.B.
Lebrun, Ivo
Flório, Jorge Camilo
Bernardi, Maria M.
Spinosa, Helenice de S.
description The moxidectin (MXD) is an antiparasitic drug used in domestic animals. The mechanism of action, in mammals, involves GABA, a neurotransmitter with an important role in the sexual behavior control. Presently, the effects of 0.2 mg/kg therapeutic dose were studied on sexual behavior, sexual motivation, penile erection and central GABA levels. Sexual behavior results showed increased latencies to the first mount and intromission as well as in inter-intromission interval; a reduction in total mounts was detected on the drug post-treatment. No difference was observed between sexual motivation of control and experimental animals. MXD treatment reduced penile erection and hypothalamic GABA levels. The results suggest that MXD reduced sexual behavior and penile erection by an action on the hypothalamic GABA system. Probably, the lack of effects in the motivational test and the increased mount and intromission latencies as well as decreased total mounts could be explained as a consequence of reduced male rat erection process.
doi_str_mv 10.1016/j.rvsc.2007.04.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1035035462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0034528807001105</els_id><sourcerecordid>2744887611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-af1e8494525fef1b513d08f504e02e014efe2426b387637a19556a506814555d3</originalsourceid><addsrcrecordid>eNp90EFr2zAUwHFROtqs6xfooRPsOntPsp5sQy9Z2bpBxw5bz0KxnxoFx8okJ7TffjIJ7DYQCMTvSeLP2I2AUoDQnzZlPKSulAB1CaoEqM7YQmAlC6m1OGeLfKIKlE1zyd6mtAEAJUR9wS5Fjdg2rV4w-hFefE_d5Efux4mio0hjRzyMPNHL3g58RWt78CF-5Dsa_UA8i-wzsGPP16-7MK3tYLe-4w_Lz0s-0IGGxIPjW5t1tFN6x944OyS6Pu1X7Onrl9_334rHnw_f75ePRadqORXWCWpUq1CiIydWKKoeGoegCCSBUORIKqlXVVPrqraiRdQWQTdCIWJfXbEPx3t3MfzZU5rMJuzjmJ80AirMS2mZlTyqLoaUIjmzi35r42tGZi5rNmYua-ayBpTJHfPQ7enq_WpL_b-RU8oM3h-Bs8HY5-iTefolQVQAjcK2xSzujiLnoYOnaFLn59i9n4uaPvj__eAv6nGSUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035035462</pqid></control><display><type>article</type><title>Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Rodrigues-Alves, Patricia S.B. ; Lebrun, Ivo ; Flório, Jorge Camilo ; Bernardi, Maria M. ; Spinosa, Helenice de S.</creator><creatorcontrib>Rodrigues-Alves, Patricia S.B. ; Lebrun, Ivo ; Flório, Jorge Camilo ; Bernardi, Maria M. ; Spinosa, Helenice de S.</creatorcontrib><description>The moxidectin (MXD) is an antiparasitic drug used in domestic animals. The mechanism of action, in mammals, involves GABA, a neurotransmitter with an important role in the sexual behavior control. Presently, the effects of 0.2 mg/kg therapeutic dose were studied on sexual behavior, sexual motivation, penile erection and central GABA levels. Sexual behavior results showed increased latencies to the first mount and intromission as well as in inter-intromission interval; a reduction in total mounts was detected on the drug post-treatment. No difference was observed between sexual motivation of control and experimental animals. MXD treatment reduced penile erection and hypothalamic GABA levels. The results suggest that MXD reduced sexual behavior and penile erection by an action on the hypothalamic GABA system. Probably, the lack of effects in the motivational test and the increased mount and intromission latencies as well as decreased total mounts could be explained as a consequence of reduced male rat erection process.</description><identifier>ISSN: 0034-5288</identifier><identifier>EISSN: 1532-2661</identifier><identifier>DOI: 10.1016/j.rvsc.2007.04.003</identifier><identifier>PMID: 17559896</identifier><language>eng</language><publisher>England: Elsevier India Pvt Ltd</publisher><subject>adrenergic receptors ; adverse effects ; animal models ; Animals ; Anthelmintics - adverse effects ; chemical concentration ; copulation ; dosage ; Drug dosages ; drug evaluation ; Female ; Females ; GABA ; GABAergic receptors ; gamma-aminobutyric acid ; gamma-Aminobutyric Acid - metabolism ; hypothalamus ; Hypothalamus - drug effects ; Hypothalamus - metabolism ; Laboratory animals ; Macrolides - adverse effects ; Male ; male reproductive system ; mechanism of action ; motivation ; Moxidectin ; Nematodes ; neurophysiology ; neurotransmitters ; pathophysiology ; Penile erection ; Penile Erection - drug effects ; Rats ; Rodents ; Sexual behavior ; Sexual Behavior, Animal - drug effects ; veterinary drugs ; Veterinary medicine</subject><ispartof>Research in veterinary science, 2008-02, Vol.84 (1), p.100-106</ispartof><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-af1e8494525fef1b513d08f504e02e014efe2426b387637a19556a506814555d3</citedby><cites>FETCH-LOGICAL-c472t-af1e8494525fef1b513d08f504e02e014efe2426b387637a19556a506814555d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rvsc.2007.04.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17559896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodrigues-Alves, Patricia S.B.</creatorcontrib><creatorcontrib>Lebrun, Ivo</creatorcontrib><creatorcontrib>Flório, Jorge Camilo</creatorcontrib><creatorcontrib>Bernardi, Maria M.</creatorcontrib><creatorcontrib>Spinosa, Helenice de S.</creatorcontrib><title>Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats</title><title>Research in veterinary science</title><addtitle>Res Vet Sci</addtitle><description>The moxidectin (MXD) is an antiparasitic drug used in domestic animals. The mechanism of action, in mammals, involves GABA, a neurotransmitter with an important role in the sexual behavior control. Presently, the effects of 0.2 mg/kg therapeutic dose were studied on sexual behavior, sexual motivation, penile erection and central GABA levels. Sexual behavior results showed increased latencies to the first mount and intromission as well as in inter-intromission interval; a reduction in total mounts was detected on the drug post-treatment. No difference was observed between sexual motivation of control and experimental animals. MXD treatment reduced penile erection and hypothalamic GABA levels. The results suggest that MXD reduced sexual behavior and penile erection by an action on the hypothalamic GABA system. Probably, the lack of effects in the motivational test and the increased mount and intromission latencies as well as decreased total mounts could be explained as a consequence of reduced male rat erection process.</description><subject>adrenergic receptors</subject><subject>adverse effects</subject><subject>animal models</subject><subject>Animals</subject><subject>Anthelmintics - adverse effects</subject><subject>chemical concentration</subject><subject>copulation</subject><subject>dosage</subject><subject>Drug dosages</subject><subject>drug evaluation</subject><subject>Female</subject><subject>Females</subject><subject>GABA</subject><subject>GABAergic receptors</subject><subject>gamma-aminobutyric acid</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>hypothalamus</subject><subject>Hypothalamus - drug effects</subject><subject>Hypothalamus - metabolism</subject><subject>Laboratory animals</subject><subject>Macrolides - adverse effects</subject><subject>Male</subject><subject>male reproductive system</subject><subject>mechanism of action</subject><subject>motivation</subject><subject>Moxidectin</subject><subject>Nematodes</subject><subject>neurophysiology</subject><subject>neurotransmitters</subject><subject>pathophysiology</subject><subject>Penile erection</subject><subject>Penile Erection - drug effects</subject><subject>Rats</subject><subject>Rodents</subject><subject>Sexual behavior</subject><subject>Sexual Behavior, Animal - drug effects</subject><subject>veterinary drugs</subject><subject>Veterinary medicine</subject><issn>0034-5288</issn><issn>1532-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90EFr2zAUwHFROtqs6xfooRPsOntPsp5sQy9Z2bpBxw5bz0KxnxoFx8okJ7TffjIJ7DYQCMTvSeLP2I2AUoDQnzZlPKSulAB1CaoEqM7YQmAlC6m1OGeLfKIKlE1zyd6mtAEAJUR9wS5Fjdg2rV4w-hFefE_d5Efux4mio0hjRzyMPNHL3g58RWt78CF-5Dsa_UA8i-wzsGPP16-7MK3tYLe-4w_Lz0s-0IGGxIPjW5t1tFN6x944OyS6Pu1X7Onrl9_334rHnw_f75ePRadqORXWCWpUq1CiIydWKKoeGoegCCSBUORIKqlXVVPrqraiRdQWQTdCIWJfXbEPx3t3MfzZU5rMJuzjmJ80AirMS2mZlTyqLoaUIjmzi35r42tGZi5rNmYua-ayBpTJHfPQ7enq_WpL_b-RU8oM3h-Bs8HY5-iTefolQVQAjcK2xSzujiLnoYOnaFLn59i9n4uaPvj__eAv6nGSUg</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Rodrigues-Alves, Patricia S.B.</creator><creator>Lebrun, Ivo</creator><creator>Flório, Jorge Camilo</creator><creator>Bernardi, Maria M.</creator><creator>Spinosa, Helenice de S.</creator><general>Elsevier India Pvt Ltd</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>20080201</creationdate><title>Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats</title><author>Rodrigues-Alves, Patricia S.B. ; Lebrun, Ivo ; Flório, Jorge Camilo ; Bernardi, Maria M. ; Spinosa, Helenice de S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-af1e8494525fef1b513d08f504e02e014efe2426b387637a19556a506814555d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>adrenergic receptors</topic><topic>adverse effects</topic><topic>animal models</topic><topic>Animals</topic><topic>Anthelmintics - adverse effects</topic><topic>chemical concentration</topic><topic>copulation</topic><topic>dosage</topic><topic>Drug dosages</topic><topic>drug evaluation</topic><topic>Female</topic><topic>Females</topic><topic>GABA</topic><topic>GABAergic receptors</topic><topic>gamma-aminobutyric acid</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>hypothalamus</topic><topic>Hypothalamus - drug effects</topic><topic>Hypothalamus - metabolism</topic><topic>Laboratory animals</topic><topic>Macrolides - adverse effects</topic><topic>Male</topic><topic>male reproductive system</topic><topic>mechanism of action</topic><topic>motivation</topic><topic>Moxidectin</topic><topic>Nematodes</topic><topic>neurophysiology</topic><topic>neurotransmitters</topic><topic>pathophysiology</topic><topic>Penile erection</topic><topic>Penile Erection - drug effects</topic><topic>Rats</topic><topic>Rodents</topic><topic>Sexual behavior</topic><topic>Sexual Behavior, Animal - drug effects</topic><topic>veterinary drugs</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodrigues-Alves, Patricia S.B.</creatorcontrib><creatorcontrib>Lebrun, Ivo</creatorcontrib><creatorcontrib>Flório, Jorge Camilo</creatorcontrib><creatorcontrib>Bernardi, Maria M.</creatorcontrib><creatorcontrib>Spinosa, Helenice de S.</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Research in veterinary science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodrigues-Alves, Patricia S.B.</au><au>Lebrun, Ivo</au><au>Flório, Jorge Camilo</au><au>Bernardi, Maria M.</au><au>Spinosa, Helenice de S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats</atitle><jtitle>Research in veterinary science</jtitle><addtitle>Res Vet Sci</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>84</volume><issue>1</issue><spage>100</spage><epage>106</epage><pages>100-106</pages><issn>0034-5288</issn><eissn>1532-2661</eissn><abstract>The moxidectin (MXD) is an antiparasitic drug used in domestic animals. The mechanism of action, in mammals, involves GABA, a neurotransmitter with an important role in the sexual behavior control. Presently, the effects of 0.2 mg/kg therapeutic dose were studied on sexual behavior, sexual motivation, penile erection and central GABA levels. Sexual behavior results showed increased latencies to the first mount and intromission as well as in inter-intromission interval; a reduction in total mounts was detected on the drug post-treatment. No difference was observed between sexual motivation of control and experimental animals. MXD treatment reduced penile erection and hypothalamic GABA levels. The results suggest that MXD reduced sexual behavior and penile erection by an action on the hypothalamic GABA system. Probably, the lack of effects in the motivational test and the increased mount and intromission latencies as well as decreased total mounts could be explained as a consequence of reduced male rat erection process.</abstract><cop>England</cop><pub>Elsevier India Pvt Ltd</pub><pmid>17559896</pmid><doi>10.1016/j.rvsc.2007.04.003</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0034-5288
ispartof Research in veterinary science, 2008-02, Vol.84 (1), p.100-106
issn 0034-5288
1532-2661
language eng
recordid cdi_proquest_journals_1035035462
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects adrenergic receptors
adverse effects
animal models
Animals
Anthelmintics - adverse effects
chemical concentration
copulation
dosage
Drug dosages
drug evaluation
Female
Females
GABA
GABAergic receptors
gamma-aminobutyric acid
gamma-Aminobutyric Acid - metabolism
hypothalamus
Hypothalamus - drug effects
Hypothalamus - metabolism
Laboratory animals
Macrolides - adverse effects
Male
male reproductive system
mechanism of action
motivation
Moxidectin
Nematodes
neurophysiology
neurotransmitters
pathophysiology
Penile erection
Penile Erection - drug effects
Rats
Rodents
Sexual behavior
Sexual Behavior, Animal - drug effects
veterinary drugs
Veterinary medicine
title Moxidectin interference on sexual behavior, penile erection and hypothalamic GABA levels of male rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A48%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Moxidectin%20interference%20on%20sexual%20behavior,%20penile%20erection%20and%20hypothalamic%20GABA%20levels%20of%20male%20rats&rft.jtitle=Research%20in%20veterinary%20science&rft.au=Rodrigues-Alves,%20Patricia%20S.B.&rft.date=2008-02-01&rft.volume=84&rft.issue=1&rft.spage=100&rft.epage=106&rft.pages=100-106&rft.issn=0034-5288&rft.eissn=1532-2661&rft_id=info:doi/10.1016/j.rvsc.2007.04.003&rft_dat=%3Cproquest_cross%3E2744887611%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035035462&rft_id=info:pmid/17559896&rft_els_id=S0034528807001105&rfr_iscdi=true